Associations of genetic variants of lysophosphatidylcholine metabolic enzymes with levels of serum lipids.

Wang, Hui; Wang, Yang; Song, Jie-Yun; Zhang, Ping-Ping; Song, Qi-Ying; Li, Chen-Xiong; Li, Li; Wang, Hai-Jun · Pediatr Res · 2022

meta_analysis · Level I

Where this comes from

Abstract

Metabolic disturbance of lysophosphatidylcholine (LPC) is related with dyslipidemia. Therefore, eight single-nucleotide polymorphisms (SNPs) were selected from LPC metabolic enzymes to study their associations with obesity and serum levels of lipids. A total of 3305 children were recruited from four independent studies. Eight SNPs of LPC metabolic enzymes were selected and genotyped with the matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS). The multivariable linear regression model was applied to detect the associations of eight SNPs with obesity-related phenotypes and levels of lipids in each study. Meta-analyses were used to combine the results of four studies. Only SNP rs4420638 of APOC-1 gene was associated with serum lipids even after Bonferroni correction. The rs4420638 was positively associated with TC (β = 0.15, P = 8.59 × 10<sup>-9</sup>) and low-density-lipoprotein-cholesterol (LDL-C, β = 0.16, P = 9.98 × 10<sup>-14</sup>) individually. The study firstly revealed the association between APOC-1/rs4420638 and levels of serum lipids in Chinese children, providing evidence for susceptible gene variants of dyslipidemia.

Medical subject headings